M Konrad

Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting

Vincent H. J. van der Velden, E. Renate Panzer‐Grümayer, Giovanni Cazzaniga et al. · Leukemia · 2007 · 149 citations

Hematological Malignancy, Medical Imaging, Pediatric Hematology +10

Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.

Louis M. Weiner, Joyce L. O'Dwyer, J Kitson et al. · PubMed · 1989 · 125 citations

Breast Oncology, Immunology, Immunotherapeutics +16

Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone

M Konrad, Markus Metzler, Simon Panzer et al. · Blood · 2003 · 94 citations · Full text

Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2.

Kolitz Je, Wong Gy, Karl Welte et al. · PubMed · 1988 · 35 citations

Immunology, Immunologic Mechanism, Pharmacotherapy +22

High incidence and unique features of antigen receptor gene rearrangements in TEL–AML1-positive leukemias

Sílvia de Oliveira Hübner, Giovanni Cazzaniga, T Flohr et al. · Leukemia · 2003 · 30 citations

Hematological Malignancy, Genetics, Immunology +8